# Total Arterial Revascularization (TAR)

> **NCT03753048** · NA · UNKNOWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 880 (estimated)

## Conditions studied

- Coronary Artery Disease
- Coronary Artery Bypass Grafting

## Interventions

- **PROCEDURE:** Y-Graft
- **PROCEDURE:** In-Situ

## Key facts

- **NCT ID:** NCT03753048
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-13
- **Primary completion:** 2023-03
- **Final completion:** 2024-03
- **Target enrollment:** 880 (ESTIMATED)
- **Last updated:** 2018-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03753048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03753048, "Total Arterial Revascularization (TAR)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03753048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*